1. Home
  2. RGP vs XGN Comparison

RGP vs XGN Comparison

Compare RGP & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$4.40

Market Cap

138.0M

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$4.68

Market Cap

110.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
XGN
Founded
1996
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
138.0M
110.7M
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
RGP
XGN
Price
$4.40
$4.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$7.00
$8.86
AVG Volume (30 Days)
716.6K
220.9K
Earning Date
04-08-2026
05-11-2026
Dividend Yield
6.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$551,331,000.00
N/A
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$13.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.06
$2.59
52 Week High
$5.95
$12.23

Technical Indicators

Market Signals
Indicator
RGP
XGN
Relative Strength Index (RSI) 46.99 54.92
Support Level $4.21 $4.11
Resistance Level $4.81 $4.93
Average True Range (ATR) 0.22 0.32
MACD -0.00 -0.02
Stochastic Oscillator 33.82 67.42

Price Performance

Historical Comparison
RGP
XGN

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: